Recurrent miscarriages: Caution regarding development of clinical trials using low molecular weight heparin and pregnancy

American Journal of Hematology

Volumn 86, Issue 2, 2011, Pages 235-235

  Misra, Dipika ^a   Aledort, Louis ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIFACTOR XA; BLOOD CLOTTING FACTOR 10; ENOXAPARIN; UNCLASSIFIED DRUG;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BINDING AFFINITY; BLOOD CLOT; CASE REPORT; CLINICAL PROTOCOL; DEEP VEIN THROMBOSIS; DRUG BINDING; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; KIDNEY FUNCTION; LEG PAIN; LEG THROMBOSIS; LETTER; PLACENTA; PLASMA VOLUME; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; RECURRENT ABORTION; RECURRENT DISEASE; SPONTANEOUS ABORTION; THROMBOSIS PREVENTION; VEIN EMBOLISM; WEIGHT GAIN;

ABORTION, HABITUAL; ADULT; ANTICOAGULANTS; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; ENOXAPARIN; FACTOR XA; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RESEARCH DESIGN; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 78751706715     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21909     Document Type: Letter

References (9)

1. Kaandorp SP, Goddijn M, van der Post JA, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010; 362: 1586-1596.
2. Laskin CA, Spitzer KA, Clark CA, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: Results from the randomized, controlled HepASA Trial. J Rheumatol 2009: 36: 279-287.
3. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005: CD002859.
4. Ziakas PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 2010: 115: 1256-1262.
5. Friedrich E, Hameed AB. Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy. J Perinatol 2010: 30: 253-257.
6. Laifer SA, Stiller RJ, Dunston-Boone G, Whetham JC. Low-molecular weight heparin for treatment of pulmonary embolism in a pregnant woman. Thromb Haemost 1999: 82: 1361-1362.
7. Lebaudy C, Hulot JS, Amoura Z, et al. Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy. Clin Pharmacol Ther 2008; 84: 370-377.
8. Casele HL, Laifer SA, Woelkers DA, Venkataramanan R. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol 1999: 181: 1113-1117.
9. Hirsh J, Bauer KA, Donati MB, Gould M, et al. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008: 133: 141S-159S.